Trending News

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Clene to Present at the Jones Healthcare and Technology Innovation Conference
Posted On Tuesday, April 01, 2025
Aptose Common Shares to Delist from Nasdaq as of April 2, 2025
Posted On Tuesday, April 01, 2025
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
Posted On Tuesday, April 01, 2025
Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025
Posted On Tuesday, April 01, 2025
Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
Posted On Tuesday, April 01, 2025
Nkarta to Participate in an April Investor Conference
Posted On Tuesday, April 01, 2025
Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients
Posted On Tuesday, April 01, 2025
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
Posted On Tuesday, April 01, 2025
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
Posted On Tuesday, April 01, 2025
Recursion to Participate in Upcoming Investor Conference
Posted On Tuesday, April 01, 2025
Phathom Pharmaceuticals Announces Leadership Succession
Posted On Tuesday, April 01, 2025
NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders
Posted On Tuesday, April 01, 2025
Avalyn Completes Successful Phase 1 Clinical Trials of AP02, its Novel Inhaled Formulation of Nintedanib, Preparing for Phase 2 Development in Idiopathic Pulmonary Fibrosis
Posted On Tuesday, April 01, 2025
RESTEM to Participate in Jones Las Vegas Technology and Innovation Conference
Posted On Tuesday, April 01, 2025
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive Year
Posted On Tuesday, April 01, 2025
Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes
Posted On Tuesday, April 01, 2025
Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme
Posted On Tuesday, April 01, 2025
Pacira BioSciences to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
Posted On Tuesday, April 01, 2025
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit
Posted On Tuesday, April 01, 2025
electroCore to Participate at the Needham Virtual Healthcare Conference
Posted On Tuesday, April 01, 2025
Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes
Posted On Tuesday, April 01, 2025
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
Posted On Tuesday, April 01, 2025
Context Therapeutics to Participate in Upcoming Investor Conferences
Posted On Tuesday, April 01, 2025
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Tuesday, April 01, 2025
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy
Posted On Tuesday, April 01, 2025

Print